Dry powder inhalers and the right things to remember: a concept review

Por Dal Negro, Roberto W
Publicado no Multidiscip Respir Med (2015)

Acceptability and preference of three inhalation devices assessed by the Handling Questionnaire in asthma and COPD patients

Por Dal Negro, Roberto W., Povero, Massimiliano
Publicado no Multidiscip Respir Med (2016)

The economic impact of educational training assessed by the Handling Questionnaire with three inhalation devices in asthma and Chronic Obstructive Pulmonary Disease patients

Por Dal Negro, Roberto W, Povero, Massimiliano
Publicado no Clinicoecon Outcomes Res (2016)

Cultural and linguistic validation of the NHQ-2 Questionnaire: a specific instrument for assessing patient’s usability of inhalation devices

Por Dal Negro, Roberto W., Povero, Massimiliano
Publicado no Multidiscip Respir Med (2016)

Dry-powder inhalers in patients with persistent airflow limitation: usability and preference

Por Dal Negro, Roberto W., Povero, Massimiliano
Publicado no Multidiscip Respir Med (2016)

The BODECOST Index (BCI): a composite index for assessing the impact of COPD in real life

Por Dal Negro, Roberto W., Celli, Bartolome R.
Publicado no Multidiscip Respir Med (2016)

Changes in blood hemoglobin and blood gases PaO(2) and PaCO(2) in severe COPD overa three-year telemonitored program of long-term oxygen treatment

Por Dal Negro, Roberto W, Tognella, Silvia, Bonadiman, Luca, Turco, Paola
Publicado em 2012

Prevalence of tracheobronchomalacia and excessive dynamic airway collapse in bronchial asthma of different severity

Por Dal Negro, Roberto W, Tognella, Silvia, Guerriero, Massimo, Micheletto, Claudio
Publicado em 2013

Cough: impact, beliefs, and expectations from a national survey

Por Dal Negro, Roberto W., Mazzolini, Massimiliano, Turco, Paola, Zanasi, Alessandro
Publicado no Multidiscip Respir Med (2016)

Costs of illness analysis in Italian patients with chronic obstructive pulmonary disease (COPD): an update

Por Dal Negro, Roberto W, Bonadiman, Luca, Turco, Paola, Tognella, Silvia, Iannazzo, Sergio
Publicado no Clinicoecon Outcomes Res (2015)

Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/ Formoterol 100/6 μg b.i.d.: a 12-week cost analysis in mild-to-moderate asthma

Por Dal Negro, Roberto W., Distante, Chiara, Bonadiman, Luca, Turco, Paola, Iannazzo, Sergio
Publicado no Multidiscip Respir Med (2016)

Cost of persistent asthma in Italy

Por Dal Negro, Roberto W., Distante, Chiara, Bonadiman, Luca, Turco, Paola, Iannazzo, Sergio
Publicado no Multidiscip Respir Med (2016)

Extent and prevalence of cognitive dysfunction in chronic obstructive pulmonary disease, chronic non-obstructive bronchitis, and in asymptomatic smokers, compared to normal referen...

Por Dal Negro, Roberto W, Bonadiman, Luca, Tognella, Silvia, Bricolo, Fernanda P, Turco, Paola
Publicado em 2014

Cognitive dysfunction in severe chronic obstructive pulmonary disease (COPD) with or without Long-Term Oxygen Therapy (LTOT)

Por Dal Negro, Roberto W, Bonadiman, Luca, Bricolo, Fernanda P, Tognella, Silvia, Turco, Paola
Publicado no Multidiscip Respir Med (2015)

Survey on attitudes of Italian pediatricians toward cough

Por Zanasi, Alessandro, Morcaldi, Luigi, Cazzato, Salvatore, Mazzolini, Massimiliano, Lecchi, Marzia, Morselli-Labate, Antonio Maria, Mastroroberto, Marianna, Dal Negro, Roberto W
Publicado no Clinicoecon Outcomes Res (2017)

Poster 1002: Galectin-3 as predictive biomarker of airways remodeling modulation in omalizumab treated severe asthma patients

Por Mauri, Pierluigi, Riccio, Annamaria, Rossi, Rossana, Di Silvestri, Dario, Benazzi, Louise, De Ferrari, Laura, Dal Negro, Roberto W, Canonica, G Walter
Publicado em 2014